Education News, Current Affairs, G.K., TET/TAT/HTAT Materials, All Exam Result & All Job Updates By JIGAR PRAJAPTI .One Step Ahead In Education....

Caller Name Broadcaster and Incoming 2022 Pro for Incoming Calls

Caller Name Broadcaster and Incoming 2022 Pro for Incoming Calls


Drug central Glenmark Pharmaceuticals has come the first Indian company to commerciallyby launch an antiviral drug for the treatment of mild to a moderate COVID-19 patients, after it received the Indian drug regulator Drug Controller General of India (DCGI) approval.work.

પ્રાથમિક શાળાના શિક્ષકોને પ્રતિભાશાળી શિક્ષક પ્રમાણપત્ર ” થી પ્રોત્સાહિત કરવા બાબત

મત્વપૂર્ણ લિંક

શિક્ષકો ને પ્રતિભાશાળી શિક્ષક પ્રમાણપત્ર એનાયત કરવા બાબત 2-12-2022 બાબત લેટર વાંચવા માટે અહીં ક્લિક કરો


મહત્વપૂર્ણ લિંક

પ્રતિભાશાળી શિક્ષક દરખાસ્ત નમૂનો ફોર્મ ડાઉનલોડ કરવા માટે અહીં ક્લિક કરો




Over 100,000,000 people already installed AVG’s antivirus mobile security apps. Join them now and:abroad.privacyExperian credit score

TET પરીક્ષા EWS પાસીંગ માર્ક અંગે ઠરાવ PDF

TET સુધારેલુ જાહેરનામુ PDF 


Photo editor

The drug Favipiravir, under the brand name FabiFlu, will be available as a 200 mg tablet at a maximum retail price (MRP) of Rs 3,500 for a strip of 34 tablets, Glenmark Pharmaceuticals said.photo!

This approval comes at a time when cases in India are spiralling like never before, putting a tremendous pressure on our healthcare system,” Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said in the statement.


Caller Name Announcer and Incoming 2021 Pro for Incoming Calls

The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer patients in India a much needed and timely therapy option, he added.

The company has successfully developed the active pharmaceutical ingredient (API) and the formulation for FabiFlu through its in-house research and development team,

“We chose to initiate work on Favipiravir, as it has proven in-vitro activity against SARS CoV2 virus, which is the virus responsible for COVID-19.

“Second is it has a wide therapeutic safety margin for Covid-19 at the dose that we administer,”Glenmark PharmaceuticalsPresident India Formulations, Middle East and AfricaSujesh Vasudevan said at an online press conference

Caller Name Announcer and Incoming 2021 Pro for Incoming Calls
It is a prescription-based medication, with recommended dose being 1,800 mg twice daily on day one, followed by 800 mg twice daily up to day 14, the drug firm said.mode.

Glenmark Pharmaceuticals Limited has announced the introduction of Favipiravir under the brand name FabiFlu in tablet form for the treatment of mild & moderate coronavirus (COVID-19) cases in India.

Nearly 80% of all COVID-19 positive cases in India are under this category. FabiFlu is India’s first oral antiviral drug for treatment of mild & moderate COVID-19 patients, the company said



Glenmark’s antiviral drug Fabiflu to be used for patients with mild and moderate symptoms

“It is a significant step in the fight against COVID-19 India. Glenmark is leading the flight. We are not looking it as a business opportunity
Tityake the drug available to as many patients and save lives,” said Sujesh Vasudevan, president, India Formulations, Middle East and Africa, Glenmark Pharmaceuticals Limited in a video conference.
ICMR recommends use of faster COVID-19 testing ki

CALLER NAME ANNOUNCER Download This App

The company had on Friday received approval from Indian drug regulator for manufacturing and marketing of Favipiravir in oral form in India.

Glenmark will work closely with the government and medical community to make FabiFlu quickly accessible to patients across the country,” he
On Saturday the company said the drug would be available from the evening near its factory areas and pan India in 7 to 10 days.
On Saturday the company said the drug would be available from the evening near its factory areas and pan India in 7 to 10 days.

jigarpajapati.blogspot.com here: Exam Notification, Exam Date, Exam Fees, Syllabus, Online Application Process, Exam Preparation Tips, Exam Study Material (General Knowledge-GK, Current Affairs , Gujarati and English Grammar, Mathematical Reasoning so Daily visit my site jigarpajapati.blogspot.com. jigarpajapati.blogspot.com is All in one Education information website, like primary Education paripatra & GR, std 1 to 8 all material, textbook, adhyayan nishpattio, Teachers Edition, Timetable, sce patrako, xamtao, pragna material all information so Daily visit This Site jigarpajapati.blogspot.com for More Updates
Important: Please always Check and Confirm the above details with the official website and Advertisement / Notification.
Tag : Application
0 C "Caller Name Broadcaster and Incoming 2022 Pro for Incoming Calls"

Search This Blog

© Copyright 2019 at www.jigarpajapati.blogspot.com

Disclaimer :
The Examination Results / Marks published in this Website is only for the immediate Information to the Examinees an does not to be a constitute to be a Legal Document. While all efforts have been made to make the Information available on this Website as Authentic as possible. We are not responsible for any Inadvertent Error that may have crept in the Examination Results / Marks being published in this Website nad for any loss to anybody or anything caused by any Shortcoming, Defect or Inaccuracy of the Information on this Website.
Back To Top